Mass tort multi-district litigation — MDL — is how the modern federal court system handles thousands of similar product liability, pharmaceutical injury, environmental exposure, and medical device cases. Unlike a class action, MDL plaintiffs keep their individual lawyers and individual cases — only the pretrial discovery and motion practice are consolidated. When the MDL finally resolves, settlements typically use point-based matrices that translate medical evidence and demographic data into individual dollar amounts. This guide walks through the entire mass-tort settlement process from JPML order to plaintiff check.
Under 28 USC § 1407, the Judicial Panel on Multidistrict Litigation (JPML) can consolidate federal civil cases pending in different districts that share common factual issues. The cases are transferred to one judge for coordinated pretrial proceedings. The goal: avoid duplicative discovery, conflicting rulings, and witness fatigue.
The JPML, composed of seven federal judges, meets quarterly to consider transfer motions. As of 2026, more than 100,000 federal civil cases are pending in active MDLs, accounting for roughly half of all federal civil filings.
| MDL | Product/Issue | Plaintiffs | Status (2026) |
|---|---|---|---|
| MDL 2741 | Roundup/glyphosate | ~150,000 (federal + state) | Partially settled (Bayer reserves $11B+) |
| MDL 2885 | 3M Combat Arms earplugs | ~260,000 | Settled 2023 ($6.01B) |
| MDL 2873 | AFFF (firefighting foam) | ~10,000+ | Pending settlements per defendant |
| MDL 3032 | Camp Lejeune water contamination | ~200,000+ (administrative) | Settlements ramping 2025-2026 |
| MDL 2974 | Paragard IUD | ~3,000 | Bellwether phase |
| MDL 3043 | Acetaminophen autism/ADHD | Pending Daubert | Causation challenged 2023-24 |
| MDL 2738 | Talc-ovarian cancer (J&J) | ~30,000+ | Active settlement (Hindman trust structures) |
| MDL 2974 | Hair relaxer | 10,000+ | Bellwether selection |
The panel orders transfer to a single transferee judge. Selection considers caseload, expertise, geographic centrality. After transfer, cases remain consolidated until pretrial is complete; they then technically return to original districts for trial (rarely happens — most settle).
The transferee judge appoints a Plaintiff Steering Committee (10-25 attorneys) and committees for trial, science, discovery, and law. PSC members carry the litigation: deposing corporate witnesses, retaining experts, drafting common-issue briefs. Non-PSC plaintiff lawyers benefit from the PSC's work but contribute to a common benefit fund.
The PSC develops causation evidence — internal corporate documents, epidemiological studies, expert testimony. The defendant moves under Daubert (FRE 702) to exclude plaintiff experts. Daubert is often the decisive moment of an MDL: if causation experts are excluded, the MDL collapses (e.g., MDL 3043 acetaminophen experts excluded December 2023). If experts survive, settlement leverage skyrockets.
The judge selects a pool of representative cases (8-30) to act as test trials. Both sides pick cases, the judge selects 3-6 from each side for actual trial. Outcomes are extrapolated to inform settlement.
If bellwether outcomes are clear (or if defendants want to avoid more), the parties enter settlement talks. Often a master settlement agreement (MSA) is negotiated between PSC leadership and defense; individual plaintiff lawyers then opt in their clients case by case.
Master settlement agreements typically include a points matrix that translates medical and demographic facts into individual award amounts. The matrix is the most important practical document for any individual plaintiff.
Defendant deposits the total settlement into a QSF (under 26 USC § 468B). The QSF holds funds during lien resolution, MSA review, and structured settlement design. Plaintiffs receive checks only when their individual claim files are complete.
A typical MDL points matrix uses tiers reflecting injury severity, treatment history, and case strength. Example structure based on the 3M Combat Arms MDL settlement framework:
| Tier | Criteria | Base Points | Multipliers |
|---|---|---|---|
| Tier 1 — Most Severe | Permanent deafness, documented military exposure, contemporaneous medical records | 100 points | ×1.2 if combat deployment, ×1.1 if service-connected disability rating ≥ 50% |
| Tier 2 — Major | Significant hearing loss, audiogram-documented, exposure period | 60 points | ×1.1 if treatment within 2 years |
| Tier 3 — Moderate | Mild-moderate loss, tinnitus only, documented exposure | 30 points | ×1.0 |
| Tier 4 — Threshold | Minimal medical evidence, brief exposure, late onset | 10 points | ×0.8 with discounts |
| Late filer penalty | Filed after fact-sheet deadlines | −20% off base points | |
| Wrongful death | Death attributable to injury | +50 points + base | Beneficiary-state dependent |
Facts: Plaintiff has 60 base points, ×1.1 multiplier = 66 final points. MDL settlement total = $1.0 billion. Total plaintiff points across all MDL claimants = 8,000,000.
For a Tier-1 plaintiff with 120 points: 120 × $125 = $15,000 gross.
Facts: Tier-1 plaintiff gross settlement $250,000.
The CBF is a "tax" on individual settlements that compensates PSC attorneys for work that helped everyone. CBF percentages vary:
The PSC files quarterly time and expense reports; the judge allocates the CBF among PSC members at the end of the MDL. Disputes can extend a year past the rest of the case.
Liens are the single largest variable in net plaintiff recovery after attorney's fees. The major lienholders:
Under the Medicare Secondary Payer Act (42 USC § 1395y), Medicare must be reimbursed for medical care related to the injury. Reimbursement is calculated by the Benefits Coordination & Recovery Center (BCRC). MDL plaintiffs face standardized Medicare resolution programs negotiated between PSC and CMS.
State Medicaid programs have liens under 42 USC § 1396a(a)(25). Resolution involves state Medicaid offices; each state has different practices.
Self-funded ERISA plans can enforce reimbursement against settlement proceeds under US Airways v. McCutchen, 569 U.S. 88 (2013). Negotiation depends on plan language; the made-whole doctrine may apply in fully-insured cases but not in ERISA self-funded.
The VA has reimbursement rights under 38 USC § 1729. Important in MDLs involving veterans (3M Combat Arms, Camp Lejeune).
State hospital lien statutes vary widely. California has aggressive lien rights; Texas is provider-friendly with statutory caps; Florida has unique balance-billing restrictions.
For Medicare-eligible plaintiffs with future injury-related care needs, an MSA allocates funds for that care. Unlike workers compensation MSAs (which CMS reviews), liability MSAs are not formally reviewed by CMS but are still required by 42 USC § 1395y(b). PSCs in major MDLs negotiate streamlined MSA procedures to avoid Medicare clawback risk.
QSF funds can be used to purchase a structured settlement annuity (under 26 USC § 130) providing tax-free periodic payments to the plaintiff. Common reasons: very large gross, minor or incapacitated plaintiff, Medicaid/SSDI eligibility preservation, retirement income planning.
| Step | Typical Duration |
|---|---|
| Master settlement agreement signing | Day 0 |
| QSF establishment | 30-60 days |
| Defendant funding QSF | 30-90 days |
| Individual plaintiff enrollment | 60-180 days |
| Points determination | 90-180 days |
| Lien resolution (Medicare/Medicaid) | 120-365 days |
| MSA review (if needed) | 60-180 days |
| Final check disbursement | 30-60 days |
| Total typical | 9-24 months from MSA |
Most master settlement agreements include defendant walk-away thresholds: if less than 95-99% of MDL plaintiffs opt in within a window, the defendant can cancel the deal. This pressures every plaintiff to opt in. Trade-off: holdouts may negotiate side deals or remain in litigation alone.
An MDL is a federal procedure created by 28 USC § 1407 that consolidates similar federal civil cases pending in different districts before a single judge for coordinated pretrial proceedings. Unlike class actions, MDL plaintiffs retain individual claims and individual lawyers — they share discovery, expert work, and bellwether trials but settle individually.
A bellwether is a representative test trial selected from the MDL inventory. Both sides pick cases (typically 3-6 each), the judge selects the bellwether pool, and individual cases proceed to jury verdict. Outcomes inform settlement negotiations across the entire MDL. Strong bellwether plaintiff verdicts pressure defendants to settle; defense verdicts pressure plaintiffs.
Modern MDL settlements typically use a point-based matrix (or 'grid') that assigns each plaintiff a point value based on injury severity, age, exposure duration, medical evidence, and other tiered criteria. Total settlement is then divided pro rata across all enrolled plaintiffs based on their points. Most allow a 'walk away' option if participation thresholds are not met.
The common benefit fund (CBF) compensates plaintiff steering committee attorneys for work done that benefits all MDL plaintiffs (discovery, depositions, expert witnesses, motions). Each plaintiff's individual settlement contributes 6-12% to the CBF. The fund is allocated among PSC attorneys by the court based on documented hours.
A QSF (26 USC § 468B) is a court-approved tax-advantaged escrow that holds settlement money before distribution to plaintiffs. Defendant deposits the full amount and receives a tax deduction at deposit; plaintiffs do not have constructive receipt until actual distribution, allowing time for lien resolution, structured settlement design, and Medicare set-aside review.
From MDL creation to final settlement: 4-10 years typically. Major examples: 3M Combat Arms (consolidated 2019, MDL settlement 2023), Roundup (2017 → 2020-2024), Camp Lejeune (PACT Act 2022 → settlements ongoing 2025-2026). Per-plaintiff payment after enrollment: typically 6-18 months.
If the plaintiff is or will be Medicare-eligible, federal law requires reasonable consideration of Medicare's future interest in injury-related medical care. An MSA allocates settlement funds for future Medicare-covered treatment. CMS reviews MSAs in workers comp; for liability cases CMS does not issue formal reviews but plaintiffs and counsel must consider Medicare's interests under 42 USC § 1395y(b).
Typical breakdown: 33-40% attorney's fee, 5-10% case costs, 6-12% common benefit fund, 5-30% liens (Medicare/Medicaid/health insurer/hospital), leaving 30-50% net to the plaintiff. Net percentage is heavily lien-dependent — a plaintiff with no lien receives much more than one with a large Medicare lien.